Abstract
Epithelial cells at mucosal surfaces constitute the first line of defense against pathogens. Intestinal epithelial cells (IECs) form a single layer of cells that isolate the host’ s internal milieu from gut luminal environment. IECs from the distal ileum and colon are in constant contact with a rich micro-bial flora, and yet, under normal conditions, no pathological inflammation is present. However, IECs possess the ability to discriminate between pathogenic and nonpathogenic bacteria because infection of these cells by pathogenic bacteria induces an inflammatory response. Because of the repertoire of proinflammatory molecules they produce when activated by microbial agents or proinflammatory cytokines, IECs can function as sensors of mucosal injury and actively participate in the innate immune mucosal response. Therefore, these cells play an essential role in the maintenance of a deli-cate balance between the defensive immune response and tolerance to local microflora. This chapter outlines some of the mechanisms by which IEC acts as sensor for microbial pathogens and how the proinflammatory response mediated by IEC plays a role in the pathogenesis of inflammatory bowel disease (IBD).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Medzhitov, R. (2001) Toll-like receptors and innate immunity. Nat. Rev. 1, 135–145.
Akashi, S., Ogata, H., Kirikae, F., Kirikae, K., Kawasaki, K., Nishijima, M, et al. (2000) Regulatory roles of CD14 and phosphatidyl inositol in the signaling via Toll-like receptor 4-MD-2. Biochem. Biophys. Res. Commun. 268, 172–177.
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., et al. (1999) MD2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777–1782.
Yang, H., Youg, F., Gusovsky, F., and Chow, J.C. (2000) Cellular events mediated by lipopolysaccharide-stimulated Toll-like receptor 4: MD-2 is required for activation of mitogen-activated protein kinases and Elk-1. J. Biol. Chem. 275 20,861.
Cario, E., Rosenberg, I.M., Brandwein, S.L., Beck, P.L ., Reinecker, H.C., and Podolsky, D.K. (2000) Lipopolysaccha-ride activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J. Immunol. 164, 966–972.
Abreu, M.T., Vora, P., Faure, E., Thomas, L.S., Arnold, A.T., and Arditi, M. (2001) Decreased expression of Toll-like receptor 4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysccharide. J. Immunol. 167, 1609–1617.
Cario, E. and Podolsky, D. ( 2000) Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68, 7010–7017.
Eaves-Pyles, T., Szabo, C., and Salsman, A.L. (1999) Bacterial invasion is not required for activation of NF-κB in enterocytes. Infect. Immun. 67, 800–804.
Elso, C.O., Cong, Y., and Sundberg, J. (2000) The C3H/HeJBir mouse model: a high susceptibility phenotype for colitis. Intern. Rev. Immunol. 19, 63–75.
Hayashi, F., Smith, K.D., Ozinsky, A., Hawn, T.R., Yi, E.C., Goodlett, D.R., et al. (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099–1103.
Gewirtz, A.T., Simon, P.O., Schmitt, C.K., Taylor, L.J., Hagedorn, C.T., O’Brien, A.D., et al. (2001) Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. J. Clin. Invest. 107, 99–109.
Gewirtz, A.T., Navas, T.A., Lyons, S., Godowski, P.J. and Madara, J.L. (2001) Cutting edge: bacterial flagellin acti-vates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167,1882–1885.
Sebastiani, G., Leveque, G., Lariviere, L., Laroche, L., Skamene, E., Gros, P. et al. (2000) Cloning and characterization of the murine Toll-like receptor 5 (TLR5) gene: sequence and mRNA expression studies in Salmonella-susceptible MOLF/Ei mice. Genomics 64, 230–240.
Garcia del Portillo, G., Stein, M.A., and Finlay, B.B. (1997) Release of lipopolysaccharide from intracellular compart-ments containing salmonella typhimurium to vesicles of the host epithelial cell. Infect. Immun. 65, 24–34.
Philpott, D.J., Yamaoka, S., Israel, A., and Sansonetti, P.J. (2000) Invasive Shigella flexneri activates NF-KB through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells. J. Immunol. 165, 903–914.
Girardin, S.E., Tournebize, R., Mavris, M., Page, A.L., Li, X., Stark, G.R., et al. (2001) CARD/Nod1 mediates NF–KB and JNK activation by invasive Shigella flexneri. EMBO Rep. 21, 736–742.
Benin, J., Nir, W.J., Fischer, C.M., Tayber, O.V., Errada, P.R., Grant, J.R., et al. (1999) Human CARD4 protein is a novel CED/Apaf-1 cell death family cell death that activates NF-κB. J. Biol. Chem. 274, 12,955–12,958.
Inoharan, N., Oguran, Y., Chenn, F.F., Muton, A. and Nunezn, G. (2001) Human nod1 confers responsiveness to bacterial lipopolysaccharides. J. Biol. Chem. 4, 2551–2554.
Inohara, N., Koseki, T., Peso, L.D., Hu, Y., Yee, C., Chen, S., et al. (1999) Nod 1, an apaf-like activator of caspase-9 and nuclear factor-κB. J. Biol. Chem 21, 14,560–14,567.
Ogura, Y., Inohara, N., Benito, A., Chen, F.F., Yamaoka, S. and Nunez, G. (2001). Nod 2, a nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J. Biol. Chem. 276, 4812–4818.
Hugot, J.P., Chamaillard, M., Zouali, H., Lesaage, S., Cezard, J.P., Belaiche, J., et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411, 599–603.
Ogura, Y., Bonen, D.K., Inohara, N., Nicolae, D.L., Chen, F.F., Ramos, P., et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411, 603–606.
Raqib, R., Lindberg, A., Wrething, B., Bardhan, P.K., Andersson, U., and Anderson, J. (1995) Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect. Immun. 63, 289–296.
Sansonetti, P.J., Arondel, J., Cavaillon, J.M., and Huerre, M. (1995) Role of IL-1 in the pathogenesis of experimental shigellosis. J. Clin. Invest. 96, 884–892.
Sansonetti, P.J., Arondel, J., Huerre, M., Hararada, A., and Matsuda, K. (1999) Interleukin-8 controls bacterial trans-epithelial translocation at the cost of epithelial destruction in experimental Shigellosis. Infect. Immun. 67, 1471–1480.
Jung, H.C., Eckmann, L., Yang, S.K., Panja, A., Fierer, J., Morzycka-Wroblewska, E., et al. (1995) A distinct array of proinflammatory cytokines is expressed in human colonic epithelial cells in response to bacterial invasion. J. Clin. Invest. 95, 55–65.
Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S.T., Weil, R., Agou, F., et al. (1998) Complementation cloning of NEMO, a component of the IkB kinase complex essential for NF-κB activation. Cell 93. 1231.
Inan, M.I., Tolmacheva, V., Qiang-Shu, W., Rosenberg, D.W., and Giardana, C. (2000) Transcription factor NF-(B participates in regulation of epithelial cell turnover in the colon. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G1282—G1291.
Wu, G.D., Huang, N., Wen, X., Keilbaugh, S.A., and Yang, H. (1999) High level expression of IkB-b in the surface epithelium of the colon: in vitro evidence for an immunomodulatory role. J. Leucocyte Biol. 66, 1049–1056.
Hermiston, M.L., and Gordon, J.I. (1995) Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270, 1203–1207.
Bocker, U, Schottelius, A, Watson, J, Holt, L, Licato, L.L, Brenner, D.A, et al. (2000) Cellular differentiation causes a selective down regulation of IL-lb-mediated NF-κB activation and IL-8 gene expression in intestinal epithelial cells. J. Biol. Chem. 275, 12,207–12,213.
Neish, A.S., Gewirtz, A.T., Zeng, H., Young, A.N., Hobert, M.E., Karmali, V., et al. (2000) Prokaryotic regulation responses by inhibition of IkB-a ubiquinisation. Science1, 1560–1563.
Neurath, M., Pettersson, S., Meyer, K.H., Zum, Buschenfelde, K.H., and Strober, W. (1996). Local administration of antisense phophothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nat. Med. 2, 998–1004.
Rogler, G. and Andus, T. (1998) Cytokines in inflammatory bowel disease. World. J. Surg. 22, 382–389.
Conner, E.M., Brand, S., Davis, J.M., Larous, F.S., Palombella, V.J., Fuseler, J.W., et al. (1997) Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis. J. Pharmacol. Exp. Ther. 283, 1–8.
Van Dullemen, H.M., Vandevnter, S.J.H, Hommes, D.W., Bijl, H.A., Jansen, J., Tytgat, G.N.J. and Woody, J. (1995) Treatment of Crohn’s disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109, 129–135.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Arbibe, L., Sansonetti, P. (2003). Host Response to Pathogenic Bacteria at Mucosal Sites. In: Kotb, M., Calandra, T. (eds) Cytokines and Chemokines in Infectious Diseases Handbook. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-309-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-59259-309-5_5
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-247-6
Online ISBN: 978-1-59259-309-5
eBook Packages: Springer Book Archive